{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T04:49:50Z","timestamp":1766551790685},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T00:00:00Z","timestamp":1311552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022718","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T20:59:35Z","timestamp":1311627575000},"page":"e22718","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cellular Immune Responses to Nine Mycobacterium tuberculosis Vaccine Candidates following Intranasal Vaccination"],"prefix":"10.1371","volume":"6","author":[{"given":"Suraj B.","family":"Sable","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mani","family":"Cheruvu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhadra","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kakali","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn L.","family":"Kellar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Posey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie B.","family":"Plikaytis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama Rao","family":"Amara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Shinnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1185449","article-title":"The population dynamics and control of tuberculosis.","volume":"328","author":"C Dye","year":"2010","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG - implications for a novel tuberculosis vaccine.","volume":"3","author":"P Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: What We Don&apos;t Know Can, and Does, Hurt Us.","volume":"328","author":"DG Russell","year":"2010","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrmicro2437","article-title":"Nanobead-based interventions for the treatment and prevention of tuberculosis.","volume":"8","author":"G Griffiths","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","article-title":"Future vaccination strategies against tuberculosis: thinking outside the box.","volume":"33","author":"SH Kaufmann","year":"2010","journal-title":"Immunity"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tube.2006.12.006","article-title":"Should a new tuberculosis vaccine be administered intranasally?","volume":"87","author":"G Kallenius","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1586\/14760584.7.9.1341","article-title":"Is intranasal vaccination a feasible solution for tuberculosis?","volume":"7","author":"PK Giri","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/17425247.3.1.87","article-title":"Noninvasive delivery technologies: respiratory delivery of vaccines.","volume":"3","author":"VJ Sullivan","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tube.2010.09.007","article-title":"Aerosol vaccines for tuberculosis: a fine line between protection and pathology.","volume":"91","author":"DA Hokey","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/infdis\/161.3.487","article-title":"Natural history of pertussis antibody in the infant and effect on vaccine response.","volume":"161","author":"J Van Savage","year":"1990","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.vaccine.2005.01.069","article-title":"Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?","volume":"23","author":"GA Rook","year":"2005","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1920","article-title":"Envisioning future strategies for vaccination against tuberculosis.","volume":"6","author":"SH Kaufmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/S0264-410X(00)00134-1","article-title":"Intranasal vaccination of mice against infection with <italic>Mycobacterium tuberculosis<\/italic>.","volume":"18","author":"G Falero-Diaz","year":"2000","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal <italic>Mycobacterium bovis<\/italic> BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.","volume":"72","author":"L Chen","year":"2004","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with <italic>Mycobacterium tuberculosis<\/italic> and boosts prior bacillus Calmette-Guerin immunity.","volume":"177","author":"J Dietrich","year":"2006","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2005.01.014","article-title":"Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu.","volume":"104","author":"ZK Carpenter","year":"2005","journal-title":"J Control Release"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.vaccine.2007.12.005","article-title":"Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of <italic>Mycobacterium bovis<\/italic> bacillus Calmette-Guerin (BCG) in infected mice.","volume":"26","author":"H Kohama","year":"2008","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"<italic>Mycobacterium tuberculosis<\/italic> arabinomannan-protein conjugates protect against tuberculosis.","volume":"21","author":"B Hamasur","year":"2003","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/IAI.70.7.3681-3688.2002","article-title":"Improved tuberculosis DNA vaccines by formulation in cationic lipids.","volume":"70","author":"S D'Souza","year":"2002","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1472-6750-10-77","article-title":"Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis.","volume":"10","author":"JCC Lorenzi","year":"2010","journal-title":"BMC Biotechnol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1196\/annals.1352.030","article-title":"Novel bacterial delivery system with attenuated <italic>Salmonella typhimurium<\/italic> carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model.","volume":"1056","author":"SK Parida","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/IAI.00793-08","article-title":"Primary activation of antigen-specific naive CD4<sup>+<\/sup> and CD8<sup>+<\/sup> T cells following intranasal vaccination with recombinant bacteria.","volume":"76","author":"A Ciabattini","year":"2008","journal-title":"Infect Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against <italic>Mycobacterium tuberculosis<\/italic> of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.","volume":"171","author":"NP Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.","volume":"173","author":"J Wang","year":"2004","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against <italic>Mycobacterium tuberculosis<\/italic> aerosol challenge in mice.","volume":"181","author":"EK Forbes","year":"2008","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.it.2010.05.002","article-title":"Airway luminal T cells: a newcomer on the stage of TB vaccination strategies.","volume":"31","author":"M Jeyanathan","year":"2010","journal-title":"Trends Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.","volume":"10","author":"H McShane","year":"2004","journal-title":"Nat Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2005.03.040","article-title":"Multicomponent antituberculous subunit vaccine based on immunodominant antigens of <italic>Mycobacterium tuberculosis<\/italic>.","volume":"23","author":"SB Sable","year":"2005","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette-guerin (BCG) vaccines expressing the <italic>Mycobacterium tuberculosis<\/italic> 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.","volume":"97","author":"MA Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant Bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.","volume":"198","author":"DF Hoft","year":"2008","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4(+) and CD8(+) T cells in adults.","volume":"181","author":"B Abel","year":"2010","journal-title":"Am J Respir and Crit Care Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.67.4.1702-1707.1999","article-title":"Differential protective efficacy of DNA vaccines expressing secreted proteins of <italic>Mycobacterium tuberculosis<\/italic>.","volume":"67","author":"AT Kamath","year":"1999","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/IAI.00267-10","article-title":"Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances <italic>Mycobacterium bovis<\/italic> BCG protective activity against <italic>Mycobacterium tuberculosis<\/italic> in mice.","volume":"78","author":"M Sali","year":"2010","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tube.2004.10.004","article-title":"A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.","volume":"85","author":"M Castanon-Arreola","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1128\/IAI.71.4.1929-1937.2003","article-title":"The Apa protein of <italic>Mycobacterium tuberculosis<\/italic> stimulates gamma interferon-secreting CD4<sup>+<\/sup> and CD8<sup>+<\/sup> T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model.","volume":"71","author":"P Kumar","year":"2003","journal-title":"Infect Immun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1099\/0022-1317-51-12-1071","article-title":"Recombinant GroES in combination with CpG oligodeoxynucleotides protects mice against <italic>Mycobacterium avium<\/italic> infection.","volume":"51","author":"L Fattorini","year":"2002","journal-title":"J Med Microbiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.vaccine.2009.01.064","article-title":"Novel prophylactic and therapeutic vaccine against tuberculosis.","volume":"27","author":"M Okada","year":"2009","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/IAI.72.12.6945-6950.2004","article-title":"A heterologous DNA priming-<italic>Mycobacterium bovis<\/italic> BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.","volume":"72","author":"JC Ferraz","year":"2004","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/IAI.00024-08","article-title":"Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8(+) T cells are sufficient to mediate protection against <italic>Mycobacterium tuberculosis<\/italic> infection.","volume":"76","author":"Y Wu","year":"2008","journal-title":"Infect Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1574-695X.2006.00087.x","article-title":"Enhanced immunoprotective potential of <italic>Mycobacterium tuberculosis<\/italic> Ag85 complex protein based vaccine against airway <italic>Mycobacterium tuberculosis<\/italic> challenge following intranasal administration.","volume":"47","author":"PK Giri","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2006.10.010","article-title":"Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.","volume":"122","author":"SB Sable","year":"2007","journal-title":"Clin Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0952-7915(02)00360-6","article-title":"T cell immunity in lymphoid and non-lymphoid tissues.","volume":"14","author":"L Lefrancois","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.it.2005.04.011","article-title":"The bone marrow: a nest for migratory memory T cells.","volume":"26","author":"F Di Rosa","year":"2005","journal-title":"Trends Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0300-9475.2004.01471.x","article-title":"The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.","volume":"60","author":"AW Olsen","year":"2004","journal-title":"Scand J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2249.2004.02648.x","article-title":"Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.","volume":"138","author":"JA Tree","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jinf.2005.12.017","article-title":"Protective efficacy of intranasal vaccination with <italic>Mycobacterium bovis<\/italic> BCG against airway <italic>Mycobacterium tuberculosis<\/italic> challenge in mice.","volume":"53","author":"PK Giri","year":"2006","journal-title":"J Infect"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/IAI.68.10.5657-5662.2000","article-title":"<italic>Mycobacterium bovis<\/italic> BCG induces similar immune responses and protection by rectal and parenteral immunization routes.","volume":"68","author":"M Abolhassani","year":"2000","journal-title":"Infect Immun"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1128\/IAI.70.3.1410-1416.2002","article-title":"Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior <italic>Mycobacterium bovis<\/italic> BCG immunization.","volume":"70","author":"U Palendira","year":"2002","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.","volume":"104","author":"HW Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1054\/tube.2002.0340","article-title":"Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with <italic>Mycobacterium tuberculosis<\/italic>.","volume":"82","author":"V Gruppo","year":"2002","journal-title":"Tuberculosis (Edinb)"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.vaccine.2005.08.001","article-title":"Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.","volume":"24","author":"MA Horwitz","year":"2006","journal-title":"Vaccine"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.femsim.2005.02.009","article-title":"Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis.","volume":"45","author":"PK Giri","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e5930","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31 (R) against <italic>Mycobacterium tuberculosis<\/italic> is highly dependent on the antigen dose.","volume":"4","author":"C Aagaard","year":"2009","journal-title":"PLoS ONE"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1128\/IAI.61.12.5294-5301.1993","article-title":"Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with <italic>Mycobacterium bovis<\/italic> BCG and <italic>Mycobacterium leprae<\/italic>.","volume":"61","author":"AS Mustafa","year":"1993","journal-title":"Infect Immun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1183\/09031936.00111205","article-title":"Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins.","volume":"29","author":"SB Sable","year":"2007","journal-title":"Eur Respir J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/jb.178.9.2498-2506.1996","article-title":"Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of <italic>Mycobacterium tuberculosis<\/italic>.","volume":"178","author":"KM Dobos","year":"1996","journal-title":"J Bacteriol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"32023","DOI":"10.1074\/jbc.274.45.32023","article-title":"Decreased capacity of recombinant 45\/47-kDa molecules (Apa) of <italic>Mycobacterium tuberculosis<\/italic> to stimulate T lymphocyte responses related to changes in their mannosylation pattern.","volume":"274","author":"C Horn","year":"1999","journal-title":"J Biol Chem"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1128\/IAI.67.11.5567-5572.1999","article-title":"Deglycosylation of the 45\/47-kilodalton antigen complex of <italic>Mycobacterium tuberculosis<\/italic> decreases its capacity to elicit <italic>in vivo<\/italic> or <italic>in vitro<\/italic> cellular immune responses.","volume":"67","author":"F Romain","year":"1999","journal-title":"Infect Immun"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1074\/jbc.M610183200","article-title":"The <italic>Mycobacterium tuberculosis<\/italic> cell-surface glycoprotein Apa as a potential adhesin to colonize target cells via the innate immune system pulmonary C-type lectin surfactant protein A.","volume":"282","author":"A Ragas","year":"2007","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1128\/IAI.68.12.6997-7002.2000","article-title":"Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages.","volume":"68","author":"WL Beatty","year":"2000","journal-title":"Infect Immun"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/IAI.01411-08","article-title":"<italic>Mycobacterium avium<\/italic> subsp paratuberculosis fibronectin attachment protein activates dendritic cells and induces a Th1 polarization.","volume":"77","author":"JS Lee","year":"2009","journal-title":"Infect Immun"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/IAI.61.2.742-750.1993","article-title":"Identification of a <italic>Mycobacterium bovis<\/italic> BCG 45\/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria.","volume":"61","author":"F Romain","year":"1993","journal-title":"Infect Immun"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R","article-title":"Role of a bacillus Calmette-Guerin fibronectin attachment protein in BCG-induced antitumor activity.","volume":"86","author":"W Zhao","year":"2000","journal-title":"Int J Cancer"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1172\/JCI116202","article-title":"Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells.","volume":"91","author":"K Kuroda","year":"1993","journal-title":"J Clin Invest"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-1759(96)00243-8","article-title":"Isolation and characterization of mouse nasal-associated lymphoid tissue.","volume":"202","author":"H Asanuma","year":"1997","journal-title":"J Immunol Methods"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor.","volume":"176","author":"K Inaba","year":"1992","journal-title":"J Exp Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T16:50:07Z","timestamp":1592758207000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022718"}},"subtitle":[],"editor":[{"given":"J\u00e9r\u00f4me","family":"Nigou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,25]]},"references-count":66,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022718","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,25]]}}}